Key result
CAC scoring in asymptomatic diabetes influences management, increasing ABC target achievement to ~56% for CAC ≥100.
Why the study?
People with diabetes mellitus remain at high cardiovascular risk, but data were needed on the severity of coronary artery calcium, its correlation with cardiovascular risk scores, and the impact of testing on management in asymptomatic Thai patients.
Does coronary artery calcium scoring improve cardiovascular risk stratification and metabolic target attainment in asymptomatic Thai people with diabetes mellitus?
Cohort (n=157)
No
Does coronary artery calcium scoring improve cardiovascular risk stratification and metabolic target attainment in asymptomatic Thai people with diabetes mellitus?
CAC scoring in asymptomatic Thai patients with diabetes reveals a high prevalence of subclinical coronary atherosclerosis and is associated with improved attainment of metabolic targets at 6 months.
Answers are grounded in this paper and cite their sources.
May support CAC-guided intensification in asymptomatic diabetes; leaves open outcome benefits without randomized data.
Background: People with diabetes mellitus (DM) remain at high risk of cardiovascular (CV) disease. The use of coronary artery calcium (CAC) has been demonstrated as the most powerful CV risk indicator and surrogate marker for the overall vascular health in the asymptomatic population. Material and Methods: This study aimed to find the severity of CAC in asymptomatic Thai people with DM, evaluate the correlation of the severity CAC risk scoring system with different CV risk scores, and examine the impacts of CAC testing on patient managements. ABC control, defined as the proportion of individuals meeting glycemic, blood pressure, and LDL cholesterol targets together, was assessed at 6 months after the CAC measurement. Zero calcium score was found in 24.2% and CAC score ≥100 AU was found in 40.3% of all patients. There was a weak to moderate significant positive correlation (correlation coefficients ranged from 0.311 to 0.449) between different CV risk scores with the presence of CAC score ≥100 AU. In those with CAC score ≥ 100 AU, aggressive lipid-lowering therapy, new prescription of SGLT2i or GLP-1 RA, new prescription of antiplatelet as primary prevention was all increased when compared with CAC <100 AU. At 6 months, achieved ABC target increased from 30.4% to 55.7% in patients with CAC ≥100 AU while achieved ABC target increased from 35.9% to 56.4% in patients with CAC < 100 AU. Conclusion: CAC is an effective tool for CV risk stratification among asymptomatic people with DM and could improve metabolic target attainment rates. Currently available clinical risk assessment models including diabetes-specific risk scores correlated weakly with results from CAC testing among Thai people with DM.
No takes yet. Share an insight, caveat, or question.
Thewjitcharoen et al. (2026) conducted a cohort in Asymptomatic Diabetes Mellitus (n=157). Coronary Artery Calcium (CAC) scoring ≥100 AU vs. CAC <100 AU was evaluated on Achieved ABC target (A1C, blood pressure, and LDL cholesterol) at 6 months. Coronary artery calcium scoring in asymptomatic Thai patients with diabetes influenced clinical management, increasing achieved ABC metabolic targets to 55.7% at 6 months in those with CAC ≥100 AU.
Synapse has enriched 10 related papers. Consider them for comparative context: